Nvidia executives struck a cautious note on the company’s China business during its quarterly earnings call Wednesday. CEO ...

Day One Biopharmaceuticals (NASDAQ:DAWN – Get Free Report)‘s stock had its “outperform” rating reissued by equities research ...

Some of the $500 billion that Apple pledged Monday to invest in the U.S. will go to the massive Taiwan Semiconductor ...

In a report released today, Daniel Ives from Wedbush maintained a Buy rating on C3ai (AI – Research Report), with a price target of $45.00. The ...

Wedbush analyst Daniel Ives maintained a Buy rating on Pegasystems (PEGA – Research Report) today and set a price target of $125.00. The ...

Analysts at Wedbush issued their FY2029 earnings per share estimates for Aerovate Therapeutics in a research report issued to clients and investors on Monday, February 24th. Wedbush analyst L. Chico ...

Dan Ives, Global Head of Technology Research at Wedbush Securities, talks about how Deepseek has transformed China's role in ...

Elon Musk's close ties to President Trump is alienating some motorists. Wall Street analysts say that could hurt Tesla.

Palantir is undoubtedly near the top of many investors' watchlists. But Wall Street estimates the company's adjusted earnings ...

Apple's investment will go to building a huge new factory in Texas to make AI data servers to producing shows and movies for ...

The vaunted chipmaker is a bellwether for tech stocks and the generative AI industry. But uncertainty has crept into views of ...

We recently compiled a list of the 20 High Growth Mega Cap Stocks You Can Buy And Hold For Next 5 Years. In this article, we ...